Camacho-Alonso F, López-Jornet P, Vicente-Hernández A. Short-term effect of zoledronic
acid upon fracture resistance of the mandibular condyle and femoral head in an animal model. Med Oral Patol Oral Cir Bucal. 2013 May 1;18 (3):e421-26.
doi:10.4317/medoral.18449
http://dx.doi.org/doi:10.4317/medoral.18449
|
1. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis
of the jaw caused by soft tissue toxicity? Bone.
2007;41:318-20. |
|
|
|
|
|
2. Hernandez CJ. How can bone turnover modify bone strength
independent of bone mass? Bone. 2008;42:1014-20. |
|
|
|
|
|
3. Burr DB, Allen MR. Low bone turnover and microdamage?
How and where to assess it? J Bone Mier Res. 2008;23:1150-1. |
|
|
|
|
|
4. Aapro
M, Abrahamsson PA, Body
JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours:
recommendations of an international expert panel. Ann Oncol. 2008;19:420-32. |
|
|
|
|
|
5. Bauss F, Pfister
T, Papapoulos S. Ibandronate
uptake in the jaw is similar to long bones and vertebrae in the rat. J Bone Miner
Metab. 2008;26:406-8. |
|
|
|
|
|
6. Allen MR, Burr DB. Changes in vertebral strength–density and energy
absorption-density relationships following bisphosphonate
treatment in beagle dogs. Osteoporos Int. 2008;19:95-9. |
|
|
|
|
|
7. Turner CH, Burr DB. Basic biomechanical measurements of bone: a
tutorial. Bone. 1993;14:595-608. |
|
|
|
|
|
8. Burr DB, Diab T, Koivunemi
A, Koivunemi M, Allen MR.
Effects of 1 to 3 years' treatment with alendronate
on mechanical properties of the femoral shaft in a canine model: implications
for subtrochanteric femoral fracture risk. J Orthop Res. 2009;27:1288-92. |
|
|
|
|
|
9. Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, et al. Higher doses of bisphosphonates further improve bone mass, architecture,
and strength but not the tissue material properties in aged rats. Bone. 2010;46:1267-74. |
|
|
|
|
|
10. Zioupos
P, Hansen U, Currey JD. Microcracking damage and the
fracture process in relation to strain rate in human cortical bone tensile
failure. J Biomech.
2008;41:2932-9. |
|
|
|
|
|
11. Ali-Erdem M, Burak-Cankaya
A, Cemil-Isler S, Demircan
S, Soluk M, Kasapoglu C,
et al. Extraction socket healing in rats treated with bisphosphonate:
animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients. Med Oral Patol Oral Cir
Bucal. 2011;16:e879-83. |
|
|
|
|
|
12. Daubine F, LE Bot
R, Márquez M, Nilsson S, Schöder
T, Holmberg AR. Treatment of bone metastasis in prostate cancer: efficacy of
a novel polybisphosphonate. Anticancer Res. 2011;31:4141-5. |
|
|
|
|
|
13. Bagán
J, Blade J, Cozar JM,
Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations
for prevention, diagnosis, and treatment of osteonecrosis
of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Med Oral Patol Oral Cir
Bucal. 2007;12:E336-40. |
|
|
|
|
|
14. Pérez SB, Barrero
MV, Hernández MS, Knezevic M, Navarro JM, Millares
JR. Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative
treatment. Med Oral Patol Oral Cir
Bucal. 2008;13:E770-3. |
|
|
|
|
|
15. Gómez Font R,
Martínez García ML, Olmos Martínez JM. Osteochemonecrosis of the jaws due
to bisphosphonate treatments. Update. Med Oral Patol Oral Cir Bucal. 2008;13:E318-24. |
|
|
|
|
|
16. Bagan
JV, Jiménez Y, Hernández S, Murillo J, Díaz JM, Poveda
R, et al. Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis:
a comparative study. Med Oral Patol Oral Ciru
Bucal. 2009;14:e616-9. |
|